Genomics company Color gains unicorn status

Color, a Burlingame, Calif.-based population genomics and healthcare technology company, achieved unicorn status Jan. 4 when it closed a $167 million series D funding round.

General Catalyst and T. Rowe Price led the funding round, with significant contributions from Viking Global Investors. 

The funding round brought Color's total financing to $278 million. It also created a valuation of $1.5 billion, which earned the seven-year-old company unicorn status.

Color plans to use the funding to strengthen its work establishing public health infrastructure and technology for governments, employers and other organizations that serve large populations.

"The opportunity to design the future of public health through technology cannot be overstated," General Catalyst Managing Director Hemant Taneja said in a news release. "Color understands that often, challenges in healthcare aren't scientific or medical in nature, but rather due to access barriers." 

More articles on digital transformation:
How CIOs are building on COVID-19 digital transformation efforts in 2021
5 recent health IT, innovation partnerships
Why CIOs are gaining more influence in front-office decision making in 2021

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Whitepapers

Featured Webinars